Cardiac Re-transplantation in Pediatrics: a Multi-Institutional Study

Survival after pediatric re-Tx is inferior to that after PTx. Re-transplantation for graft failure and rejection are associated with high relative risks for death. Given the limitations of donor availability, re-Tx for early graft failure and rejection appear contraindicated but appears acceptable for those who have survived ≥1 year after their PTx, especially those with graft coronary artery disease.